×

Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors

  • US 20040052785A1
  • Filed: 07/09/2003
  • Published: 03/18/2004
  • Est. Priority Date: 01/09/2001
  • Status: Abandoned Application
First Claim
Patent Images

1. A pharmaceutical composition comprising an agent or agents having (i) at least one receptor tyrosine kinase blocking specificity and (ii) at least one angiogenesis inhibiting specificity, wherein said agent or agents is/are not a cytokine immunoconjugate, optionally together with a pharmaceutically acceptable carrier, diluent or recipient.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×